RhumbLine Advisers’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-37,155
| Closed | -$150K | – | 4294 |
|
|
2023
Q4 | $150K | Buy |
37,155
+9,197
| +33% | +$37.2K | ﹤0.01% | 3310 |
|
|
2023
Q3 | $75.2K | Buy |
27,958
+661
| +2% | +$1.78K | ﹤0.01% | 3547 |
|
|
2023
Q2 | $255K | Buy |
27,297
+1,475
| +6% | +$13.8K | ﹤0.01% | 3107 |
|
|
2023
Q1 | $229K | Buy |
25,822
+820
| +3% | +$7.27K | ﹤0.01% | 2705 |
|
|
2022
Q4 | $125K | Buy |
25,002
+154
| +0.6% | +$770 | ﹤0.01% | 2877 |
|
|
2022
Q3 | $144K | Buy |
24,848
+1,443
| +6% | +$8.36K | ﹤0.01% | 2956 |
|
|
2022
Q2 | $129K | Buy |
+23,405
| New | +$129K | ﹤0.01% | 3010 |
|